Back to Results
First PageMeta Content
Pharmacology / Nootropics / Health / Stimulants / Childhood psychiatric disorders / Attention deficit hyperactivity disorder / Atomoxetine / Methylphenidate / Rebound effect / Medicine / Attention-deficit hyperactivity disorder / Chemistry


CHAPTER 7: PHARMACOLOGICAL TREATMENT OF ADHD Principles for Medical Treatment Seventeen Considerations in Medication Selection in the Treatment of ADHD209 1. Age and individual variation 2. Duration of effect 3. Speed of
Add to Reading List

Document Date: 2014-11-10 14:14:53

Open Document

File Size: 425,19 KB

Share Result on Facebook

City

Quebec City / /

Company

AMP / /

Country

Canada / /

Facility

Laval University / /

IndustryTerm

insurance coverage / immediate-release products / soft food / extended health insurance / treatment for core symptoms / /

MedicalCondition

ADHD / headaches / HIV / chronic disorder / substance use disorder / motor hyperactivity / bipolar disorders / comorbid disorder / disorder / mood disorders / restlessness / primary disorder / severe disorder / comorbid disorders / depression / severe anxiety disorder / Comorbid psychiatric disorder / /

MedicalTreatment

adjunctive therapy / sustained-release preparations / /

Organization

CAP-Guidelines Committee / Laval University in Quebec / Therapeutic Products Directorate / Canadian government / American Academy of Child and Adolescent Psychiatry / /

Position

teacher / Physician / /

Product

Specific Medication / triad / Concerta / modafinil / ADHD medication / Canadian ADHD Medication / What medication / MPH-Based Medication / Is medication / Ritalin / /

ProvinceOrState

Quebec / /

Technology

pharmacogenetics / /

URL

www.caddra.ca / /

SocialTag